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Temporal Trends in Analgesic Use in Long-Term Care
Facilities: A Systematic Review of International Prescribing
Francesca L. La Frenais, BSc,*† Rachel Bedder, MSc,*‡ Victoria Vickerstaff, MSc,† Patrick Stone,
MA, MD,† and Elizabeth L. Sampson, MD†§
OBJECTIVES: To explore global changes in the prescrip-
tion of analgesic drugs over time in the international long-
term care (LTC) population.
DESIGN: Systematic review.
SETTING: We included original research articles in Eng-
lish, published and unpublished, that included number of
participants, country and year(s) of data collection, and
prescription of analgesics (analgesics not otherwise speci-
fied, opioids, acetaminophen; scheduled only, or scheduled
plus as needed (PRN)).
PARTICIPANTS: LTC residents.
MEASUREMENTS: We searched PubMed, EMBASE,
CINAHL, International Pharmaceutical Abstracts, Psy-
cINFO, Cochrane, Web of Science, Google Scholar, using
keywords for LTC facilities and analgesic medication;
hand-searched references of eligible papers; correspon-
dence. Studies were quality rated using an adapted New-
castle-Ottawa scale. Pearson correlation coefficients were
generated between percentage of residents prescribed an
analgesic and year of data collection. If available, we
investigated changes in acetaminophen and opioid
prescriptions.
RESULTS: Forty studies met inclusion criteria. A moder-
ate correlation (0.59) suggested that scheduled prescription
rates for analgesics have increased over time. Similar find-
ings were reflected in scheduled prescriptions for acetami-
nophen and opioids. No increase was seen when analyzing
scheduled plus PRN analgesics. Use of opioids (scheduled
plus PRN) appears to have increased over time.
CONCLUSION: Worldwide, use of opioids and acetami-
nophen has increased in LTC residents. Research is needed
to explore whether this reflects appropriate pain
management for LTC residents and if PRN medication is
used effectively. J Am Geriatr Soc 2017.
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A long-term care (LTC) facility is an institution provid-ing accommodation, meals, 24-hour staffing, and in
some cases 24-hour nursing care. In 2011, in the United
States, 3.9% of individuals aged 65 and older received
LTC,1 similar to other developed countries.2,3
It is suggested that LTC residents are undertreated for
pain4–6; common painful diseases affecting LTC residents
include musculoskeletal disorders, cancer, pressure sores,
and neuropathies.7,8 A large European study estimated that
pain affected 48.4% of LTC residents, with 12.0% report-
ing uncontrolled pain,9 consistent with other countries,5,6
including a U.S. study that found that 23.0% of residents
reporting persistent pain did not receive scheduled anal-
gesics.10 Dementia is often underdiagnosed in this popula-
tion11; cognitively impaired residents may not remember,
understand, or communicate their pain, presenting a com-
plex challenge for care staff assessing pain.12,13 Poorly
managed pain can lead to distress, poor quality of life,14,15
worsening cognition, and depression.16,17
Prescribers should take a stepwise approach from
nonopioids, used for mild to moderate pain (e.g., acetami-
nophen, considered a first-line treatment because it is well
tolerated) to opioids, generally used for severe acute pain
or chronic pain but with risk of side effects such as seda-
tion, constipation, nausea, and vomiting. In older adults
multimorbidity and polypharmacy increase the likelihood
of adverse events.8,18,19
Review Aims
Our aim was to investigate whether, and how, interna-
tional prescribing patterns of analgesic medication for
LTC residents have changed over time. Specific objectives
were to explore changes in the prescription of analgesic
drugs, explore changes in prescribing of opioids and
From the *Division of Psychiatry; †Division of Psychiatry, Marie Curie
Palliative Care Research Department; ‡Institute of Cognitive Neuroscience,
University College London; and §Barnet Enfield and Haringey Mental
Health Trust Liaison Team, North Middlesex University Hospital,
London, United Kingdom.
Address correspondence to Francesca La Frenais, Division of Psychiatry,
University College London, 6th Floor, Maple House, 149 Tottenham




© 2017 The Authors.
Journal of the American Geriatrics Society published by Wiley Periodicals, Inc. on behalf of The American Geriatrics Society. 0002-8614/17/$15.00
This is an open access article under the terms of the Creative Commons Attribution License, which permits use,
distribution and reproduction in any medium, provided the original work is properly cited.
acetaminophen; and examine changes in scheduled medica-




We used a three-step search strategy. To refine the search
terms, an initial limited search of PubMed was run, fol-
lowed by analysis of the text words and Medical Subject
Heading terms contained in the title, abstract, and index
of identified papers. Then a search was run using identified
key words and index terms (for LTC facilities and anal-
gesics; see Appendix S1) across included databases until
December 2016 (PubMed (including Medline, 1966–pre-
sent), EMBASE (1947–present), CINAHL (1937–present),
International Pharmaceutical Abstracts (1970–present),
PsycINFO (1880s–present), Cochrane (1898–present), Web
of Science (1900–present) and Google Scholar). There were
no restrictions on country. Finally, references of included
articles were hand searched.
Eligibility Criteria
Original research articles reporting prescribing of anal-
gesics in LTC facilities were included. Single case studies
and studies not published in English were excluded.
Setting
We included LTC facilities (residential homes (institution
with board, meals, 24-hour staffing), nursing homes (as
before plus 24-hour nurse coverage), group dwellings (if
deemed suitable based on description)). We excluded
assisted living accommodations, sheltered accommoda-
tions, retirement apartments, and hospitals.
Study Population
Included participants were residents in an eligible setting
where the majority of participants were aged 55 and older
in studies that did not focus on a specific illness or condi-
tion. A study population was ineligible if it consisted of
newly admitted (admission <3 months) residents; those
diagnosed with a specific illness, those receiving palliative
care, individuals who were included only if they were
deemed to be in pain; individuals who were included only
because of polypharmacy; incidence of adverse drug event;
incidence of fall or recent hospital admission; if dementia
or cognitive impairment were excluded; mild cognitive
impairment or severe cognitive impairment only; or where
residents with severe impairment were excluded, and the
number of residents in the excluded population exceeded
the number of included participants.
Data
One reviewer (FL) independently screened titles, abstracts,
and full-text articles and extracted the number or
percentage of residents prescribed analgesics (including
analgesic-antipyretics), opioids, or acetaminophen; the
total number of participants; if available the number of
LTC facilities; and year and country of data collection. Data
were ineligible if prescriptions included drugs that were
potentially not for analgesia (e.g., MO1 drug class) or anal-
gesics combined with other medications, such as disease-
modifying antirheumatic products; only PRN data were
available; medication was recorded only if the drug was
administered within a specific time window (unless daily,
when it was counted as scheduled only); or only weighted
percentages were given. If authors indicated that they had
collected relevant but unpublished information, they were
contacted. There was no restriction on study design. Ran-
domized controlled trials were included if baseline data
were published. For longitudinal studies, data were ana-
lyzed from the first time point that was at least 3 months
after admission to the LTC facility to avoid confounding
variables associated with newly admitted residents.
Data Extraction and Quality Checking
Two researchers independently extracted and reviewed data
(FL, RB). Eligible studies were assessed for methodological
validity using a 5-point scale (Appendix S2) adapted from
the Newcastle-Ottawa scale20 and Boyle scale.21 Studies
were deemed strong, moderate, or weak (adapted from
Boyle21) by rating representativeness of the target cohort,
adequacy and standardization of data collection tools, par-
ticipation rate, and inclusion of cluster sampling in analysis.
If a study did not account for cluster sampling, it was
demoted by 1 quality rating. If answers were unclear, the
authors were contacted. If they could not be reached, we
used the lowest score for that item. Final scores were
resolved through discussion and with a third independent
author (ELS).
Analysis
The percentage of residents prescribed analgesics was calcu-
lated to one decimal place. Data were specified as scheduled
drugs only or scheduled plus PRN; if not explicitly men-
tioned, they were deemed to be scheduled plus PRN. Arti-
cles that included scheduled medications and scheduled plus
PRN medications or published data from 2 time points were
divided into “cohorts” for separate analysis. Analgesic med-
ications were coded using the Anatomical Therapeutic
Chemical classification system22 (Appendix S3).
We quantified study heterogeneity (I2 > 75% is con-
siderable heterogeneity). If the data were statistically
viable, we planned to meta-analyze them, but if that was
not possible, we planned to generate correlation coeffi-
cients using the Pearson correlation. The Pearson correla-
tion is sensitive to outliers, so we planned to exclude
extreme outliers, identified from the scatter plot, if there
was sufficient clinical justification to do so based on the
original article’s discussion. Stata version 14 (Stata Corp.,
College Station, TX) was used.
RESULTS
Of 14,323 citations reviewed, 40 studies were included
(Figure 1). From the 40 studies, 50 cohorts were eligible.
Supplementary Appendix S4 describes study characteristics
and quality ratings.
2 LA FRENAIS ET AL. 2017 JAGS
Data were divided according to prescription type:
scheduled only (n = 15) or scheduled plus PRN (n = 35).
For scheduled only, the median number of participants per
study was 551 (range 215–7,309). For scheduled plus PRN
prescriptions, the median was 595 (range 13–16,126).
Data were available from 16 countries. One study
included data from across Europe (excluding Italy). The
countries with the most cohorts were Australia (n = 8),
Norway (n = 7), and the United States (n = 6). All other
cohorts were from Europe, North America, and Australia.
We were unable to meta-analyze because of heterogeneity
(prescriptions of scheduled analgesics I2 = 99.1, scheduled
plus PRN analgesics, I2 = 99.8).
Quality Rating
Six cohorts were scored as being of strong quality, 20 as
moderate, and 24 as weak. The main reasons for low
scores were authors not using cluster sampling and lack of
detail about data collection methods.
Analgesics
Temporal Changes in Prescriptions of Scheduled
Analgesics
Fifteen cohorts were eligible (Table 1) (data drawn from
17,670 residents and at least 490 LTC facilities in 8 coun-
tries). Two studies,23,24 accounting for 7,545 residents, did
not provide the number of included LTC facilities.
Figure 2 suggests that, between 1996 and 2015, anal-
gesic prescribing increased in LTC facilities. Data from a
Norwegian study show that 23% of residents were pre-
scribed scheduled analgesics in 1996, compared with
57.6% in 2011.19,25 Two studies, both from Germany,
reported lower levels: one26 reported that 33.7% of resi-
dents were prescribed scheduled analgesics in 2014, and
another27 reported a 32% prescription rate in 2010. The
correlation between prescription prevalence and final year
of data collection was 0.59, showing a moderate positive
trend.
Temporal Changes in Prescriptions of Scheduled
Opioids and Acetaminophen
Ten studies included data on opioid prescriptions (correla-
tion coefficients (Rs) = 0.94), and eight on acetaminophen
prescriptions (Rs = 0.93, excluding one outlier that
reported very low acetaminophen use (2.5%)). The
Full-text arcles excluded, with reasons (n = 496)
Ineligible medicaon data  (263)
Ineligible cohort due to parcipant characteriscs (83)
Not in English (44)
Ineligible cohort due to medicaon criteria for inclusion 
(42)
Ineligible publicaon type  (20)
Community or care home not separate (17)
Informaon not available or provided (16)
Ineligible seng (16)
Duplicate cohort (8)
Unable to ﬁnd (7)
Records idenﬁed through 
database searching
(n = 14,323)
Records aer duplicates removed (n = 9677)
Records screened
(n = 9677)
Full-text arcles assessed 
for eligibility
(n = 536)
Included studies (n = 40)
Cohorts included (n = 50)
Records excluded (n = 9143)
Addional records idenﬁed 
through other sources
(n = 38)
Figure 1. Flow diagram of study selection.














Tan, Visvanathan54,a,b 2014 Australia 75.2
Bauer, Pitzer55,b 2012 Austria 52
Veal, Bereznicki23,b 2012 Australia 62.8
Sandvik, Selbaek19,a,b 2011 Norway 57.6
K€olzsch, Wulff27 2010 Germany 32
Kr€uger, Folkestad56,b 2008 Norway 54.8
L€ovheim, Karlsson24,a,b 2006 Sweden, Finland 60.6
Reynolds, Hanson32 2004 United States 32
Sandvik, Selbaek19,a,b 2004 Norway 45




Sandvik, Selbaek19,a,b 2000 Norway 34.9
Nygaard, Naik58,a,b 1997 Norway 29.9
Nygaard and Naik25 1996 Norway 23
aAcetaminophen data available.
bOpioid data available.
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number of scheduled prescriptions of opioids and acetami-
nophen has increased over time.
Temporal Changes in Prescriptions of Scheduled Plus
PRN Analgesics
Thirty-one cohorts were eligible (73,938 residents, at least
526 LTC facilities in 16 countries plus Europe, excluding
Italy; Table 2). There were 10 cohorts, accounting for
46,211 residents, that did not provide the number of LTC
facilities included.
Because the scatter plot did not suggest a trend, it was
not appropriate to run a correlation. Scheduled plus PRN
prescriptions have not changed since 1984. Several stud-
ies24,28,29 show very high prescribing rates (>90%). One of
the most recent studies (from 2013) reported the lowest
prescribing rate (16%).30 Of the four U.S. studies, the ear-
liest (1990) reported that 38.3% of residents were pre-
scribed analgesics,31 compared with 68.6% in 2004.32
Temporal Changes in Prescriptions of Scheduled Plus
PRN Opioids and Acetaminophen
For scheduled plus PRN prescriptions for opioids and acet-
aminophen over time, there was a positive linear trend for
opioids over time, with a moderate correlation coefficient
(0.48). It appears that scheduled plus PRN prescriptions




We have demonstrated a multinational trend of increased
prescription of scheduled analgesics, with corroborative
findings for acetaminophen and opioids. Intracountry lon-
gitudinal studies (e.g., increases in Norway between 2000
and 2011) and intercountry comparisons (in 2000–01,
34.9% of Norwegian residents and 45.9% of Dutch resi-
dents were prescribed analgesics, and in 2011–12, 57.6%
of Norwegian residents and 62.8% Australian residents
were prescribed analgesics) support this finding.19,23,33
There does not appear to be a temporal trend for
scheduled plus PRN prescribing. This may be because
there is no explicit guidance regarding assessment before
giving PRN medication12 and individual clinical preference
continues to influence prescribing.
As expected, acetaminophen remained the most com-
monly prescribed analgesic,4,23,34 and prescriptions have
increased. The exception is Germany, probably because of
the frequent use of dipyrone, a drug banned in several
other countries because of risk of agranulocytosis.26
Several factors may have influenced increases in opioid
prescriptions. Clinicians are more cautious about nons-
teroidal antiinflammatory drugs (NSAIDS) and may pre-
scribe opioids as an alternative. A Finnish study saw a
reduction in NSAID use in LTC facilities from 13.0% in
2003 to 2.6% in 2011,35 as did a Norwegian study (6.8%
in 2000 to 3.2% in 2011), alongside increases in opioids
and acetaminophen.19 Concerns have been expressed that
opioids are used for their sedative effect, not just pain.13,35
Another concern is that opioids may be wrongly prescribed
for neuropathic pain, for which an adjuvant drug may be
more effective; the prevalence of adjuvant drugs does not
match the prevalence of neuropathic pain.19,35
More detailed studies have identified that strong opi-
oids are used more than weak opioids.4,19,36 The introduc-
tion of buprenorphine and fentanyl patches may have
contributed to use of strong opioids.37 A Danish study
reported that nursing home residents were more likely to
receive transdermal opioids.13 Their use may be appealing
because of ease of administration,38 but U.S. and U.K.
guidelines advise that extended-release opioids should not
be the first choice because of negative side effects.18,38–40
Quality Rating
The ranges of prescribing prevalence were similar for high-
and low-quality studies. It is troubling that there were so
few high-quality studies (6 out of 50 cohorts). There was
no clear indication that higher-quality studies produced
mutually consistent results in terms of prescribing preva-
lence, which may be because of the heterogeneity of sam-
ples and settings.
Cultural Factors
Several studies found a low prevalence of analgesic use. In
Italy, 24% of residents reporting pain did not receive anal-
gesics, and authors commented that medication was nei-
ther appropriately nor effectively managing pain.30 A
Dutch study reported that 38% of residents in “substan-
tial” pain received no analgesics, noting that pain was not
included in national nursing home performance indica-
tors.41 Another study reported remarkably low analgesic
use in Poland. Only 28.8% of residents received anal-
gesics, and only 21.4% of these received scheduled pain
relief. Authors commented that pain is not routinely
assessed in nursing homes.42 Where low analgesic use is
reported, authors often describe a cultural climate that
does not prioritize pain assessment. In Italy, where low
rates of analgesic prescriptions are reported,4 nonpharma-































1995 2000 2005 2010 2015
Year data collection ended
Figure 2. Percentage of residents prescribed scheduled anal-
gesic medication over time.
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Limitations
Sample sizes varied greatly, from primary data collection
studies involving 1 LTC facility to databases of thousands.
One doctor or practice typically manages LTC prescribing,
which is thus subject to individual preferences. Data from
a small number of facilities may indicate less typical pre-
scribing patterns than a larger sample and contribute to
the high levels of observed heterogeneity. Conversely, it
can be more difficult to ensure reliability of database
records because they depend on accurate input from the
LTC facility.43 There were no studies from South America,
Africa, or Asia, and conclusions are not generalizable out-
side Western Europe, North America, and Australia.
Lastly, it has been suggested that neuropathic pain, esti-
mated to be present in 8% to 11% of elderly and nursing
home populations,44,45 is often treated inappropriately.
This review has not explored prescriptions of neuropathic
analgesics because they may be prescribed for other condi-
tions, and most studies do not collect information on pre-
scribing indications.
Clinical and Policy Implications
Many countries have shifted from NSAID use, and in their
place other analgesics may be prescribed. In Australia,
2005 national prescribing guidelines, which highlighted
good practice in pain management in residential care,23,46
may be influencing increasing analgesic use, and a UK
increase in fentanyl use may have occurred after its licens-
ing for noncancer pain in 2002. There has been growing
interest in pain in individuals with dementia and LTC
facilities highlighting undertreatment,9,12 leading to greater
use of assessment tools and treatment guidelines.8,18,47
Furthermore, there has been more research into behavioral
and psychological symptoms of dementia and pain.48,49
These studies, combined with policy pressure to limit use
of psychotropics, such as the Omnibus Budget Reconcilia-
tion Act of 1987, may have contributed to the increase in
analgesic prescriptions, particularly opioids.50,51
Future Research Needed
An increase in analgesic prescribing does not necessarily
mean that residents are receiving the most appropriate treat-
ment,36 and more frequent pain assessment does not neces-
sarily equate to more analgesia.52 Medication is often
prescribed as needed, and administration depends upon staff
and their ability to assess pain accurately. This is particularly
relevant for cognitively impaired residents who cannot com-
municate their pain; regular prescriptions may ensure that
this population is at less risk of undertreatment.53 Research
into using clinical decision-making algorithms (with stepped
treatment approaches), greater collaboration between profes-
sionals such as pharmacists and palliative care nurses, and
developing interventions to empower and engage the whole
care team involved in regularly assessing pain and evaluating
pain management strategies could address the disconnect
between recognizing and treating pain.37
CONCLUSION
This is the first systematic review to investigate changes in
prescribing patterns of analgesics in the international LTC
population. We included data from all studies reporting
analgesic use and demonstrated that increases in prescrib-
ing seen in smaller studies are representative of an interna-
tional upward trend, providing a context for current
prescribing practices in LTC facilities and insight into the
influence of research focus and policy changes.
Table 2. Cohorts Included in Analysis of Scheduled





















Onder, Vetrano30,b 2013 Italy 16




Veal, Bereznicki23 2012 Australia 90.8
Taxis, Kochen60,b 2009 Australia,
Netherlands
80.8





Stafford, Alswayan61 2007 Australia 56.8
Torvik, Kaasa62,b 2006 Norway 54.7




Roughead, Gilbert65,a 2005 Australia 53.8
Reynolds, Hanson32 2004 United States 68.6
Bergman, Olsson66,b 2003 Sweden 61.5
Snowdon, Day67 2003 Australia 63.6




Jyrkka, Vartiainen68 1998 Finland 54
King69,a,b 1997 Australia 74
O’Grady and Weedle70 1997 Ireland 20
Kaasalainen, Middleton29 1996 Canada 95
Neutel, Perry71 1996 Canada 33.5
Van Dijk, de Vries72,b 1995 Netherlands 53
King69,a,b 1994 Australia 60.9




Williams, Nichol31 1990 United States 38.3
Passmore, Crawford75 1989 Northern Ireland 24.8
Hatton76 1987 England 43
Nolan and O’Malley77 1987 Ireland 27
Yakabowich, Keeley78 1987 Canada 58.5
Primrose, Capewell79 1984 Scotland 32
aAcetaminophen data available.
bOpioid data available.
JAGS 2017 TEMPORAL TRENDS IN ANALGESIC PRESCRIBING 5
ACKNOWLEDGMENTS
Financial Disclosure: F. La Frenais’s PhD is supported by
the Marie Curie Palliative Care Research Department and
the MARQUE Programme (Chief Investigator Professor
Gill Livingston), which is funded by the National Institute
for Health Research/Economic and Social Research Coun-
cil (Grant Reference 512810).
Conflict of Interest: None.
Author Contributions: FL, ES, PS: Conception and
design of review, development of search strategy. FL: Study
selection, data extraction from included studies. FL, RB:
Quality rating and data extraction. FL, ES, VV: Data analy-
sis. FL., ES, PS, VV: Interpretation and discussion of results.
FL: Drafting the manuscript. ES, PS: Revision of the manu-
script. All authors approved the final version of the article.
Sponsor’s Role: None.
REFERENCES
1. OECD Health Policy Studies, OECD Publishing. A Good Life in Old Age?
Monitoring and Improving Quality in Long-Term Care. Paris: OECD
Health Policy Studies, OECD Publishing, 2013.
2. Knapp M, Comas-Herrera A, Somani A et al. Dementia: International
Comparisons. London, UK: Personal Social Services Research Unit, London
School of Economics and Political Science and the Institute of Psychiatry,
King’s College London, 2007.
3. Changes in the Older Resident Care Home Population. Between 2001 and
2011. London: Office for National, Statistics, 2014.
4. Lukas A, Mayer B, Fialova D et al. Treatment of pain in European nursing
homes: Results from the Services and Health for Elderly in Long TERm
Care (SHELTER) study. J Am Med Dir Assoc 2013;14:821–831.
5. Hughes L, Hanslip J, Witham M. Centrally active prescribing for nursing
home residents-how are we doing? Eur Geriatr Med 2012;3:304–307.
6. K€onner F, Budnick A, Kuhnert R et al. Interventions to address deficits of
pharmacological pain management in nursing home residents-A cluster-ran-
domized trial. Eur J Pain 2015;19:1331–1341.
7. Ahn H, Stechmiller J, Fillingim R et al. Bodily pain intensity in nursing
home residents with pressure ulcers: Analysis of national minimum data set
3.0. Res Nurs Health 2015;38:207–212.
8. AGS Panel. Pharmacological management of persistent pain in older per-
sons. J Am Geriatr Soc 2009;57:1331.
9. Lukas A, Mayer B, Fialova D et al. Pain characteristics and pain control in
European nursing homes: Cross-sectional and longitudinal results from the
Services and Health for Elderly in Long TERm care (SHELTER) Study. J
Am Med Dir Assoc 2013;14:421–428.
10. Lapane KL, Quilliam BJ, Chow W et al. Pharmacologic management of
non-cancer pain among nursing home residents. J Pain Symptom Manage
2013;45:33–42.
11. Buhr GT, Kuchibhatla M, Clipp EC. Caregivers’ reasons for nursing home
placement: Clues for improving discussions with families prior to the tran-
sition. Gerontologist 2006;46:52–61.
12. Barry HE, Parsons C, Passmore AP et al. Pain in care home residents with
dementia: An exploration of frequency, prescribing and relatives’ perspec-
tives. Int J Geriatr Psychiatry 2014;30:55–63.
13. Jensen-Dahm C, Gasse C, Astrup A et al. Frequent use of opioids in
patients with dementia and nursing home residents: A study of the entire
elderly population of Denmark. Alzheimer’s Dement 2015;11:691–699.
14. Corbett A, Husebo BS, Achterberg WP et al. The importance of pain
management in older people with dementia. Br Med Bull 2014;111:
139–148.
15. Katz N. The impact of pain management on quality of life. J Pain Symp-
tom Manage 2002;24(1 Suppl):S38–S47.
16. Parmelee PA, Katz IR, Lawton MP. The relation of pain to depression
among institutionalized aged. J Gerontol 1991;46:15–21.
17. Fishbain DA, Cutler R, Rosomoff HL et al. Chronic pain-associated
depression: Antecedent or consequence of chronic pain? A review. Clin J
Pain 1997;13:116–137.
18. Abdulla A, Adams N, Bone M et al. Guidance on the management of pain
in older people. Age Ageing 2013;42:i1–i57.
19. Sandvik R, Selbaek G, Kirkevold O et al. Analgesic prescribing patterns in
Norwegian nursing homes from 2000 to 2011: Trend analyses of four data
samples. Age Ageing 2016;45:54–60.
20. Wells G, Shea B, O’Connell D et al. The Newcastle-Ottawa Scale (NOS)
for assessing the quality of nonrandomised studies in meta-analyses, 2000.
[on-line]. Available at http://www.ohri.ca/programs/clinical_epidemiology/
oxford.asp Accessed June 3, 2016.
21. Boyle MH. Guidelines for evaluating prevalence studies. Evid Based Ment
Health 1998;1:37–39.
22. World Health Organization. Analgesics Norway: WHO Collaborating Cen-
tre for Drug Statistics; 2015 [on-line]. Available at http://www.whocc.no/
atc_ddd_index/?code=N02&showdescription=yes Accessed May 29, 2016.
23. Veal FC, Bereznicki LR, Thompson AJ et al. Pharmacological management
of pain in Australian aged care facilities. Age Ageing 2014;43:851–856.
24. L€ovheim H, Karlsson S, Gustafson Y. The use of central nervous system
drugs and analgesics among very old people with and without dementia.
Pharmacoepidemiol Drug Saf 2008;17:912–918.
25. Nygaard H, Naik M. Drug use in homes for the aged. A comparison
between mentally intact and mentally impaired residents. Aging (Milan,
Italy) 1999;11:186–193.
26. Hoffmann F, Schmiemann G. Pain medication in German nursing homes:
A whole lot of metamizole. Pharmacoepidemiol Drug Saf 2016;25:646–
651.
27. K€olzsch M, Wulff I, Ellert S et al. Deficits in pain treatment in nursing
homes in Germany: A cross-sectional study. Eur J Pain 2012;16:439–446.
28. Jervis LL, Shore J, Hutt E et al. Suboptimal pharmacotherapy in a tribal
nursing home. J Am Med Dir Assoc 2007;8:1–7.
29. Kaasalainen S, Middleton J, Knezacek S et al. Pain and cognitive status in
the institutionalized elderly: Perceptions & interventions. J Gerontol Nurs
1998;24:24–31; quiz 50–51.
30. Onder G, Vetrano DL, Cherubini A et al. Prescription drug use among
older adults in Italy: A country-wide perspective. J Am Med Dir Assoc
2014;15:531.e11–e15.
31. Williams BR, Nichol MB, Lowe B et al. Medication use in residential care
facilities for the elderly. Ann Pharmacother 1999;33:149–155.
32. Reynolds KS, Hanson LC, DeVellis RF et al. Disparities in pain manage-
ment between cognitively intact and cognitively impaired nursing home res-
idents. J Pain Sympt Manag 2008;35:388–396.
33. Smalbrugge M, Jongenelis LK, Pot AM et al. Pain among nursing home
patients in the Netherlands: Prevalence, course, clinical correlates, recogni-
tion and analgesic treatment—an observational cohort study. BMC Geriatr
2007;7:1.
34. Miu DKY, Chan KC. Under-detection of pain in elderly nursing home resi-
dents with moderate to severe dementia. J Clin Gerontol Geriatr
2014;5:23–27.
35. Pitkala KH, Juola AL, Hosia H et al. Eight-year trends in the use of
opioids, other analgesics, and psychotropic medications among institu-
tionalized older people in Finland. J Am Med Dir Assoc 2015;16:973–
978.
36. Ruscitto A, Smith BH, Guthrie B. Changes in opioid and other analgesic
use 1995–2010: Repeated cross-sectional analysis of dispensed prescribing
for a large geographical population in Scotland. Eur J Pain 2015;19:59–66.
37. Achterberg W. Pain management in long-term care: Are we finally on the
right track? Age Ageing 2016;45:7–8.
38. Vadivelu N, Hines RL. Management of chronic pain in the elderly: Focus
on transdermal buprenorphine. Clin Interv Aging 2008;3:421–430.
39. NICE. Palliative Care for Adults: Strong Opioids for Pain Relief. NICE
Clinical Guideline, Contract No.: 140. UK: NICE, 2012.
40. Dowell D, Haegerich T, Chou R. CDC Guideline for Prescribing Opioids
for Chronic Pain United States, 2016.
41. Boerlage A, Masman A, Tibboel D et al. Is pain measurement a feasible
performance indicator for Dutch nursing homes? A cross-sectional
approach. Pain Manag Nurs 2013;14:36–40.
42. Neumann-Podczaska A, Nowak T, Suwalska A et al. Analgesic use among
nursing homes residents, with and without dementia, in Poland. Clin Interv
Aging 2016;11:335–340.
43. Lix LM, Yan L, Blackburn D et al. Agreement between administrative data
and the Resident Assessment Instrument Minimum Dataset (RAI-MDS) for
medication use in long-term care facilities: A population-based study. BMC
Geriatr 2015;15:24.
44. Kollenburg EG, Lavrijsen J, Verhagen SC et al. Prevalence, causes, and
treatment of neuropathic pain in Dutch nursing home residents: A retro-
spective chart review. J Am Geriatr Soc 2012;60:1418–1425.
45. Torrance N, Smith BH, Bennett MI et al. The epidemiology of chronic pain
of predominantly neuropathic origin. Results from a general population
survey. J Pain 2006;7:281–289.
46. The Australian Pain Society. Pain in Residential Aged Care Facilities Man-
agement Strategies. Sydney: The Australian Pain Society, 2005.
47. Corbett A, Achterberg W, Husebo B et al. An international road map to
improve pain assessment in people with impaired cognition: The
6 LA FRENAIS ET AL. 2017 JAGS
development of the Pain Assessment in Impaired Cognition (PAIC) meta-
tool. BMC Neurol 2014;14:1–14.
48. Sampson EL, White N, Lord K et al. Pain, agitation, and behavioural prob-
lems in people with dementia admitted to general hospital wards: A longi-
tudinal cohort study. Pain 2015;156:675–683.
49. Tosato M, Lukas A, van der Roest HG et al. Association of pain with behav-
ioral and psychiatric symptoms among nursing home residents with cognitive
impairment: Results from the SHELTER study. Pain 2012;153:305–310.
50. Banerjee S. The Use of Antipsychotic Medication for People with Demen-
tia: Time for Action. London: Department of Health, 2009.
51. Hawes C, Mor V, Phillips CD et al. The OBRA-87 nursing home regula-
tions and implementation of the Resident Assessment Instrument: Effects
on process quality. J Am Geriatr Soc 1997;45:977–985.
52. Petyaeva A, Kajander M, Lawrence V et al. Feasibility of a staff training and
support programme to improve pain assessment and management in people
with dementia living in care homes. Int J Geriatr Psychiatry 2017 May 5.
Available at http://www.onlinelibrary.wiley.com/doi/10.1002/gps.4727/full
Accessed October 11, 2017.
53. Veal FC, Bereznicki LR, Thompson AJ et al. Use of opioid analgesics in
older Australians. Pain Med 2015;16:1519–1527.
54. Tan EC, Visvanathan R, Hilmer SN et al. Analgesic use and daytime
sleepiness in residents with and without dementia in residential aged care
facilities. Drugs Aging 2015;32:1045–1053.
55. Bauer U, Pitzer S, Schreier MM et al. Pain treatment for nursing home resi-
dents differs according to cognitive state—a cross-sectional study. BMC
Geriatr 2016;16:124.
56. Kr€uger K, Folkestad M, Geitung J-T et al. Psychoactive drugs in seven
nursing homes. Prim Health Care Res Dev 2012;13:244–254.
57. Decker SA, Culp KR, Cacchione PZ. Evaluation of musculoskeletal pain
management practices in rural nursing homes compared with evidence-
based criteria. Pain Manag Nurs 2009;10:58–64.
58. Nygaard HA, Naik M, Ruths S et al. Nursing-home residents and their
drug use: A comparison between mentally intact and mentally impaired res-
idents. Eur J Clin Pharmacol 2003;59:463–469.
59. Kaasalainen S, Wickson-Griffiths A, Akhtar-Danesh N et al. The effective-
ness of a nurse practitioner-led pain management team in long-term care:
A mixed methods study. Int J Nurs Stud 2016;62:156–167.
60. Taxis K, Kochen S, Wouters H et al. Cross-national comparison of medica-
tion use in Australian and Dutch nursing homes. Age Ageing 2017;46:320–
323. Erratum in: Age Ageing 2017 Jan 13.
61. Stafford AC, Alswayan MS, Tenni PC. Inappropriate prescribing in older
residents of Australian care homes. J Clin Pharm Ther 2011;36:33–44.
62. Torvik K, Kaasa S, Kirkevold Ø et al. Pain in patients living in Norwegian
nursing homes. Palliat Med 2008;23:8–16.
63. Carey IM, De Wilde S, Harris T et al. What factors predict potentially
inappropriate primary care prescribing in older people? Drugs Aging
2008;25:693–706.
64. Elseviers MM, Vander Stichele RR, Van Bortel L. Drug utilization in Bel-
gian nursing homes: Impact of residents’ and institutional characteristics.
Pharmacoepidemiol Drug Saf 2010;19:1041–1048.
65. Roughead EE, Gilbert AL, Woodward MC. Medication use by Australian
war veterans in residential aged-care facilities. J Pharm Pract Res
2008;38:14–18.
66. Bergman A, Olsson J, Carlsten A et al. Evaluation of the quality of drug
therapy among elderly patients in nursing homes: A computerized phar-
macy register analysis. Scand J Prim Health Care 2007;25:9–14.
67. Snowdon J, Day S, Baker W. Audits of medication use in Sydney nursing
homes. Age Ageing 2006;35:403–408.
68. Jyrkka J, Vartiainen L, Hartikainen S et al. Increasing use of medicines in
elderly persons: A five-year follow-up of the Kuopio 75 + Study. Eur J Clin
Pharmacol 2006;62:151–158.
69. King MA. Medication Care: Databases, Drug Use and Outcomes. Brisbane,
Australia: University of Queensland, 2003.
70. O’Grady M, Weedle P. A descriptive study of drug therapy and cost for
elderly residents in a nursing home. Irish Med J 1997;91:172–174.
71. Neutel CI, Perry S, Maxwell C. Medication use and risk of falls. Pharma-
coepidemiol Drug Saf 2002;11:97–104.
72. Van Dijk K, de Vries CS, Van den Berg P et al. Drug utilisation in Dutch
nursing homes. Eur J Clin Pharmacol 2000;55:765–771.
73. Ferrell BA, Ferrell BR, Osterweil D. Pain in the nursing home. J Am Geri-
atr Soc 1990;38:409–414.
74. Vander Stichele R, Mestdagh J, Van Haecht C et al. Medication utilization
and patient information in homes for the aged. Eur J Clin Pharmacol
1992;43:319–321.
75. Passmore A, Crawford V, Beringer T et al. Determinants of drug utilization
in an elderly population in North and West Belfast. Pharmacoepidemi Drug
Saf 1995;4:147–160.
76. Hatton P. “Primum non nocere”—an analysis of drugs prescribed to
elderly patients in private nursing homes registered with Harrogate Health
Authority. Care Elderly 1990;2:166–169.
77. Nolan L, O’Malley K. The need for a more rational approach to drug
prescribing for elderly people in nursing homes. Age Ageing 1989;18:52–
56.
78. Yakabowich MR, Keeley G, Montgomery PR. Impact of a formulary on
personal care homes in Manitoba. Can Med Assoc J 1994;150:1601–
1610.
79. Primrose WR, Capewell AE, Simpson GK et al. Prescribing patterns
observed in registered nursing homes and long-stay geriatric wards. Age
Ageing 1987;16:25–28.
SUPPORTING INFORMATION
Additional Supporting Information may be found in the
online version of this article:
Appendix S1. Search terms used in each database
Appendix S2. Adapted quality rating scale
Appendix S3. Anatomical Therapeutic Chemical codes
used to describe analgesics included in cohorts
Appendix S4. Table of included cohorts: study charac-
teristics and quality ratings
Please note: Wiley-Blackwell is not responsible for the
content, accuracy, errors, or functionality of any support-
ing materials supplied by the authors. Any queries (other
than missing material) should be directed to the corre-
sponding author for the article.
JAGS 2017 TEMPORAL TRENDS IN ANALGESIC PRESCRIBING 7
